Eligi
Med
Base de datos
Seguridad
Sobre EligiMed
Contacto
Contáctenos
Ensayos Clínicos | EligiMed
Ensayos clínicos
8.676 ensayos encontrados
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Double-blind, Multicenter Trial to Evaluate the Safety and Efficacy of Sequential (Intravenous, Oral) Moxifloxacin Versus Comparator in Pediatric Subjects With Complicated Intra-abdominal Infection
INTERVENTIONAL
Inicio: 21 de jul de 2010
ID: NCT01069900
Completado
Fase 4
ClinicalTrials.gov
Hospitalization and Mortality in Iron Deficient, Anemic Patients With Chronic Kidney (CKD) and Heart Failure Receiving Intravenous Iron Therapy: A Five Year Follow-up From a Pilot Study
INTERVENTIONAL
Inicio: 1 de mar de 2006
ID: NCT02392910
Completado
ClinicalTrials.gov
Rolandic Epilepsy Genomewide Association International Study
OBSERVATIONAL
Inicio: 1 de jun de 2018
ID: NCT03547050
Terminado
Fase 3
ClinicalTrials.gov
A Phase II/III, Multicenter, Randomized, Placebo-controlled Study of Gemcitabine Plus Cisplatin With or Without Bintrafusp Alfa (M7824) as First-line Treatment of Biliary Tract Cancer
INTERVENTIONAL
Inicio: 20 de sept de 2019
ID: NCT04066491
Completado
Fase 3
ClinicalTrials.gov
A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, 52-Wk Study to Evaluate the Efficacy and Safety of Belimumab (HGS1006, LymphoStat-B™), a Fully Human Monoclonal Anti-BLyS Antibody, in Subjects With Systemic Lupus Erythematosus (SLE)
INTERVENTIONAL
Inicio: 1 de may de 2007
ID: NCT00424476
Completado
ClinicalTrials.gov
A Long-Term Follow-up Study of Subjects Who Participated in a Clinical Trial in Which Asunaprevir (BMS-650032) and/or Daclatasvir (BMS-790052) Was Administered for the Treatment of Chronic Hepatitis C
OBSERVATIONAL
Inicio: 7 de feb de 2012
ID: NCT01492504
Completado
ClinicalTrials.gov
Non-invasive Assessment of Lung Recruitment in Morbid Obese Patients Undergoing Bariatric Surgery
INTERVENTIONAL
Inicio: 11 de sept de 2016
ID: NCT03694665
Completado
Fase 3
ClinicalTrials.gov
A Clinical Outcomes Study to Compare the Incidence of Major Adverse Cardiovascular Events in Subjects Presenting With Acute Coronary Syndrome Treated With Losmapimod Compared to Placebo (PM1116197) LosmApimod To Inhibit p38 MAP Kinase as a TherapeUtic Target and moDify Outcomes After an Acute Coronary syndromE (LATITUDE)-TIMI 60.
INTERVENTIONAL
Inicio: 3 de jun de 2014
ID: NCT02145468
Completado
Fase 3
ClinicalTrials.gov
A Phase 3, Multi-center, Double-blind, Placebo-controlled, Parallel-arm Trial to Determine Long-term Safety and Efficacy of Oral Tolvaptan Tablets Regimens in Adult Subjects With Autosomal Dominant Polycystic Kidney Disease
INTERVENTIONAL
Inicio: 1 de ene de 2007
ID: NCT00428948
Retirado
Fase 3
ClinicalTrials.gov
A Multicenter, Randomized, Double-Blind, Active and Placebo-Controlled 16-Week Study Followed by Long Term Evaluation of Efficacy and Safety of Ixekizumab (LY2439821) in Patients With Active Ankylosing Spondylitis
INTERVENTIONAL
Inicio: 1 de jul de 2014
ID: NCT01870284
Completado
Fase 3
ClinicalTrials.gov
Multicenter, Randomized, Double-blind, Phase III Trial to Investigate the Efficacy and Safety of Oral BIBF 1120 Plus Standard Pemetrexed Therapy Compared to Placebo Plus Standard Pemetrexed Therapy in Patients With Stage IIIB/IV or Recurrent Non Small Cell Lung Cancer After Failure of First Line Chemotherapy
INTERVENTIONAL
Inicio: 1 de dic de 2008
ID: NCT00806819
Terminado
Fase 2
ClinicalTrials.gov
A Phase II, Multicenter, Randomized, Open-label, Active Controlled Study to Evaluate the Safety and Efficacy of Micafungin Salvage Mono-therapy Versus Active Control Intravenous Salvage Mono-therapy in Patients With Invasive Aspergillosis
INTERVENTIONAL
Inicio: 1 de jun de 2006
ID: NCT00376337
Completado
Fase 3
ClinicalTrials.gov
A Phase III Randomized, Double Blind, Placebo-controlled Trial Comparing Capecitabine Plus Sorafenib Versus Capecitabine Plus Placebo in the Treatment of Locally Advanced or Metastatic HER2-Negative Breast Cancer
INTERVENTIONAL
Inicio: 21 de feb de 2011
ID: NCT01234337
Desconocido
ClinicalTrials.gov
Transversal, Multicentric Study for Early Detection of Drug Interactions in Older Hospitalized Patients Using on Line Software in Córdoba, Argentina
OBSERVATIONAL
Inicio: 1 de jun de 2009
ID: NCT00850330
Terminado
Fase 2
ClinicalTrials.gov
A Phase IIb, Randomized (Stratified), Double-Blind (Sponsor Open), Parallel-Group, Placebo-Controlled, Dose-Finding Study of Nemiralisib (GSK2269557) Added to Standard of Care (SoC) Versus SoC Alone in Participants Diagnosed With an Acute Moderate or Severe Exacerbation of Chronic Obstructive Pulmonary Disease (COPD)
INTERVENTIONAL
Inicio: 28 de nov de 2017
ID: NCT03345407
Completado
Fase 4
ClinicalTrials.gov
Pulses of Vincristine and Dexamethasone During Maintenance in BFM Protocols for Children With Intermediate-Risk Acute Lymphoblastic Leukemia
INTERVENTIONAL
Inicio: 1 de abr de 1995
ID: NCT00411541
Terminado
Fase 2
ClinicalTrials.gov
An Adaptive Phase II Study to Evaluate the Efficacy, Pharmacodynamics, Safety and Tolerability of GSK2586184 in Patients With Mild to Moderate Systemic Lupus Erythematosus
INTERVENTIONAL
Inicio: 1 de mar de 2013
ID: NCT01777256
Completado
ClinicalTrials.gov
Artificial Intelligence Screening for Body Dysmorphic Disorder in Aesthetic Surgery: Improving Patient Safety and Outcomes
OBSERVATIONAL
Inicio: 2 de ene de 2021
ID: NCT06584305
Completado
Fase 3
ClinicalTrials.gov
A Phase III, Randomized, Double Blind, Placebo-controlled Clinical Study to Assess the Efficacy and Safety of GSK2402968 in Subjects With Duchenne Muscular Dystrophy
INTERVENTIONAL
Inicio: 2 de dic de 2010
ID: NCT01254019
Terminado
Fase 2
ClinicalTrials.gov
An Open-Label, Multicenter Phase 1/2 Dose Escalation and Expansion Study of THOR-707 as a Single Agent and as a Combination Therapy in Adult Subjects With Advanced or Metastatic Solid Tumors
INTERVENTIONAL
Inicio: 20 de jun de 2019
ID: NCT04009681
Anterior
1
...
409
410
411
...
434
Siguiente
Filtros